183 related articles for article (PubMed ID: 31029968)
1. Chemical-genetic interaction landscape of mono-(2-ethylhexyl)-phthalate using chemogenomic profiling in yeast.
Alfatah M; Wong JH; Kong KW; Utama F; Hoon S; Arumugam P
Chemosphere; 2019 Aug; 228():219-231. PubMed ID: 31029968
[TBL] [Abstract][Full Text] [Related]
2. Disruption of ergosterol and tryptophan biosynthesis, as well as cell wall integrity pathway and the intracellular pH homeostasis, lead to mono-(2-ethylhexyl)-phthalate toxicity in budding yeast.
Jiang L; Wang L; Fang T; Papadopoulos V
Chemosphere; 2018 Sep; 206():643-654. PubMed ID: 29783050
[TBL] [Abstract][Full Text] [Related]
3. Chemical activity-based environmental risk analysis of the plasticizer di-ethylhexyl phthalate and its main metabolite mono-ethylhexyl phthalate.
Gobas FAPC; Otton SV; Tupper-Ring LF; Crawford MA; Clark KE; Ikonomou MG
Environ Toxicol Chem; 2017 Jun; 36(6):1483-1492. PubMed ID: 27859543
[TBL] [Abstract][Full Text] [Related]
4. Endocrine disruption: In silico perspectives of interactions of di-(2-ethylhexyl)phthalate and its five major metabolites with progesterone receptor.
Sheikh IA; Abu-Elmagd M; Turki RF; Damanhouri GA; Beg MA; Al-Qahtani M
BMC Struct Biol; 2016 Sep; 16(Suppl 1):16. PubMed ID: 27719669
[TBL] [Abstract][Full Text] [Related]
5. Testicular toxicity induced by single dosing of di- and mono-(2-ethylhexyl) phthalate in the rat.
Teirlynck O; Kaufman JM; Bogaert MG; Roels H
Toxicol Lett; 1988 Jan; 40(1):85-91. PubMed ID: 3124304
[TBL] [Abstract][Full Text] [Related]
6. Effects of di-(2-ethylhexyl) phthalate and five of its metabolites on rat testis in vivo and in in vitro.
Sjöberg P; Bondesson U; Gray TJ; Plöen L
Acta Pharmacol Toxicol (Copenh); 1986 Mar; 58(3):225-33. PubMed ID: 3716815
[TBL] [Abstract][Full Text] [Related]
7. Phthalic acid is the main metabolite of the plasticizer di(2-ethylhexyl) phthalate in peritoneal dialysis patients.
Mettang T; Alscher DM; Pauli-Magnus C; Dunst R; Kuhlmann U; Rettenmeier AW
Adv Perit Dial; 1999; 15():229-33. PubMed ID: 10682108
[TBL] [Abstract][Full Text] [Related]
8. The metabolism of di(2-ethylhexyl) phthalate (DEHP) and mono-(2-ethylhexyl) phthalate (MEHP) in rats: in vivo and in vitro dose and time dependency of metabolism.
Lhuguenot JC; Mitchell AM; Milner G; Lock EA; Elcombe CR
Toxicol Appl Pharmacol; 1985 Aug; 80(1):11-22. PubMed ID: 4024100
[TBL] [Abstract][Full Text] [Related]
9. Exposure of newborn infants to plasticizers. Plasma levels of di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate during exchange transfusion.
Sjöberg PO; Bondesson UG; Sedin EG; Gustafsson JP
Transfusion; 1985; 25(5):424-8. PubMed ID: 4049487
[TBL] [Abstract][Full Text] [Related]
10. Biological monitoring of the five major metabolites of di-(2-ethylhexyl)phthalate (DEHP) in human urine using column-switching liquid chromatography-tandem mass spectrometry.
Preuss R; Koch HM; Angerer J
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):269-80. PubMed ID: 15664359
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of alternative mechanisms of blood and testes disposition of di(2-ethylhexyl) phthalate and mono(2-ethylhexyl) phthalate in rats.
Keys DA; Wallace DG; Kepler TB; Conolly RB
Toxicol Sci; 1999 Jun; 49(2):172-85. PubMed ID: 10416263
[TBL] [Abstract][Full Text] [Related]
12. Non-linearities in the pharmacokinetics of di-(2-ethylhexyl) phthalate and metabolites in male rats.
Sjöberg P; Bondesson U; Hammarlund M
Arch Toxicol; 1985 Dec; 58(2):72-7. PubMed ID: 4091659
[TBL] [Abstract][Full Text] [Related]
13. Mono-2-ethylhexyl phthalate, a metabolite of di-(2-ethylhexyl) phthalate, causally linked to testicular atrophy in rats.
Albro PW; Chapin RE; Corbett JT; Schroeder J; Phelps JL
Toxicol Appl Pharmacol; 1989 Sep; 100(2):193-200. PubMed ID: 2781553
[TBL] [Abstract][Full Text] [Related]
14. Phthalates Are Metabolised by Primary Thyroid Cell Cultures but Have Limited Influence on Selected Thyroid Cell Functions In Vitro.
Hansen JF; Brorson MM; Boas M; Frederiksen H; Nielsen CH; Lindström ES; Hofman-Bang J; Hartoft-Nielsen ML; Frisch T; Main KM; Bendtzen K; Rasmussen ÅK; Feldt-Rasmussen U
PLoS One; 2016; 11(3):e0151192. PubMed ID: 26985823
[TBL] [Abstract][Full Text] [Related]
15. Use of di(2-ethylhexyl) phthalate-containing medical products and urinary levels of mono(2-ethylhexyl) phthalate in neonatal intensive care unit infants.
Green R; Hauser R; Calafat AM; Weuve J; Schettler T; Ringer S; Huttner K; Hu H
Environ Health Perspect; 2005 Sep; 113(9):1222-5. PubMed ID: 16140631
[TBL] [Abstract][Full Text] [Related]
16. PPARβ/δ-ANGPTL4 axis mediates the promotion of mono-2-ethylhexyl phthalic acid on MYCN-amplified neuroblastoma development.
Liu Y; Hamid N; Manzoor R; Zhang BF; Liao YL; Wang JX; Pei DS
Sci Total Environ; 2024 Feb; 912():168949. PubMed ID: 38042186
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and metabolism of monoethylhexyl phthalate and diethylhexyl phthalate: a survey of recent literature.
Thomas JA; Northup SJ
J Toxicol Environ Health; 1982 Jan; 9(1):141-52. PubMed ID: 7038132
[TBL] [Abstract][Full Text] [Related]
18. Mono(2-ethylhexyl)phthalate and mono-n-butyl phthalate activation of peroxisome proliferator activated-receptors alpha and gamma in breast.
Venkata NG; Robinson JA; Cabot PJ; Davis B; Monteith GR; Roberts-Thomson SJ
Toxicol Lett; 2006 Jun; 163(3):224-34. PubMed ID: 16326050
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of di(2-ethylhexyl) phthalate (DEHP) by various tissues and cytochrome P450s of human and rat.
Choi K; Joo H; Campbell JL; Clewell RA; Andersen ME; Clewell HJ
Toxicol In Vitro; 2012 Mar; 26(2):315-22. PubMed ID: 22186153
[TBL] [Abstract][Full Text] [Related]
20. Fetotoxic effects of mono-2-ethylhexyl phthalate (MEHP) in mice.
Tomita I; Nakamura Y; Yagi Y; Tutikawa K
Environ Health Perspect; 1986 Mar; 65():249-54. PubMed ID: 3709449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]